MIRAMED
0544.920.858 · rovalta.com · 25/09/2026
ACTIVE
MIRAMED
Financial year 2024 · Closed on 31/12/2024
Net result132,4 k €+7,9 %over 1 year
Gross margin209,1 k €-16,3 %over 1 year
Equity677,8 k €0,0 %over 1 year
Overview
Identity
Source · BCE/KBOMIRAMED is a Private limited company incorporated in 2014. Its registered office is in Sambreville.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0544.920.858
- Incorporation
- 31/01/2014
- Legal form
- Private limited company
- Registered office
- Rue Hicguet(AUV) 2
5060 Sambreville · WallonieSee on map - Contributed capital
- 20 000,00 €
- Latest accounts
- 31/12/2024
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 209,1 k € | -16.3% | 249,9 k € | +48.4% | 168,3 k € | +29.6% | 129,9 k € | -19.9% | 162,2 k € |
| EBITDA | 199,9 k € | -12.9% | 229,4 k € | +38.6% | 165,6 k € | +36.5% | 121,3 k € | -24.2% | 160 k € |
| Operating result | 159,4 k € | -8.1% | 173,4 k € | +51.7% | 114,3 k € | +48.3% | 77,1 k € | -35.5% | 119,6 k € |
| Net result | 132,4 k € | +7.9% | 122,7 k € | +76.8% | 69,4 k € | +47.1% | 47,2 k € | -45.7% | 86,8 k € |
| Balance sheet | |||||||||
| Equity | 677,8 k € | 0.0% | 677,8 k € | 0.0% | 677,8 k € | +11.4% | 608,4 k € | +8.4% | 561,3 k € |
| Total assets | 1,4 M € | +4.5% | 1,3 M € | +12.0% | 1,2 M € | +8.5% | 1,1 M € | +7.1% | 1 M € |
| Cash | 47,1 k € | +41.7% | 33,2 k € | +9.3% | 30,4 k € | +20.2% | 25,3 k € | -74.8% | 100,2 k € |
| Debts | 714,8 k € | +9.1% | 655 k € | +27.8% | 512,5 k € | +5.0% | 488,3 k € | +5.4% | 463,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20241 active · 4 ended
Active mandates
MARIA BELOVICI
ActiveEnded mandates
Maria BELOVICI
EndedBELOVICI MARIA
EndedMaria BELOVICI
EndedMARIA BELOVICI
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/10/2025 | 27/02/2025 | 30/09/2023 | 01/10/2022 | 30/11/2021 | 17/12/2020 |
| General meeting | 13/06/2025 | 10/06/2024 | 09/06/2023 | 31/12/2021 | 11/06/2021 | 11/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 13/06/2025 | 08/10/2025 | French | |
| Micro model | 31/12/2023 | 10/06/2024 | 27/02/2025 | French | |
| Micro model | 31/12/2022 | 09/06/2023 | 30/09/2023 | French | |
| Micro model | 31/12/2021 | 31/12/2021 | 01/10/2022 | French | |
| Micro model | 31/12/2020 | 11/06/2021 | 30/11/2021 | French | |
| Micro model | 31/12/2019 | 11/12/2020 | 17/12/2020 | French | |
| Micro model | 31/12/2018 | 14/06/2019 | 26/11/2019 | French | |
| Micro model | 31/12/2017 | 08/06/2018 | 02/12/2018 | French | |
| Abridged model | 31/12/2016 | 09/06/2017 | 15/09/2017 | French | |
| Abridged model | 31/12/2015 | 10/06/2016 | 22/07/2016 | French | |
| Abridged model | 31/12/2014 | 12/06/2015 | 20/07/2015 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 4 ended
Active mandates
MARIA BELOVICI
ActiveEnded mandates
Maria BELOVICI
EndedBELOVICI MARIA
EndedMaria BELOVICI
EndedMARIA BELOVICI
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024132,4 k €↑
- 2023Annual accounts 2023122,7 k €↑
- 2023Name changeMIRAMED
- 2022Annual accounts 202269,4 k €↑
- 2021Annual accounts 202147,2 k €↓
- 2021Name changeDOCTEUR BELOVICI MARIA
- 2020Annual accounts 202086,8 k €↓
- 2019Annual accounts 201996,5 k €↑
- 2018Annual accounts 201811,1 k €↓
- 2017Annual accounts 2017163,1 k €↑
- 2016Annual accounts 2016139 k €↑
- 2015Annual accounts 2015-57,3 k €↓
- 2014Annual accounts 2014212,1 k €
- 31/01/2014IncorporationPrivate limited company